Towards EU regulatory hazard assessment of metabolic endocrine disrupters: Integrating new biomarkers into OECD test guidelines

Claire Beausoleil, Christophe Rousselle, Eren Ozcagli, Miriam N. Jacobs

Open source

DOI
10.1016/j.yrtph.2026.106041
Published
2026-05
Container
Regulatory Toxicology and Pharmacology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.yrtph.2026.106041,
  title = {Towards EU regulatory hazard assessment of metabolic endocrine disrupters: Integrating new biomarkers into OECD test guidelines},
  author = {Claire Beausoleil and Christophe Rousselle and Eren Ozcagli and Miriam N. Jacobs},
  year = {2026},
  journal = {Regulatory Toxicology and Pharmacology},
  doi = {10.1016/j.yrtph.2026.106041},
  url = {https://doi.org/10.1016/j.yrtph.2026.106041}
}

RIS

TY  - JOUR
TI  - Towards EU regulatory hazard assessment of metabolic endocrine disrupters: Integrating new biomarkers into OECD test guidelines
AU  - Claire Beausoleil
AU  - Christophe Rousselle
AU  - Eren Ozcagli
AU  - Miriam N. Jacobs
PY  - 2026
JO  - Regulatory Toxicology and Pharmacology
DO  - 10.1016/j.yrtph.2026.106041
UR  - https://doi.org/10.1016/j.yrtph.2026.106041
ER  - 

APA

Beausoleil, C., Rousselle, C., Ozcagli, E., & Jacobs, M. N. (2026). Towards EU regulatory hazard assessment of metabolic endocrine disrupters: Integrating new biomarkers into OECD test guidelines. Regulatory Toxicology and Pharmacology. https://doi.org/10.1016/j.yrtph.2026.106041

Source records